CT chest, abdomen, and pelvis

AUG 13, 2026 · PHASE 1/2 TRIAL

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 1/2 trial registry record with no posted results; the study has been terminated and no efficacy or safety outcomes are reported in this document.